Dr Susan Chung, MD | |
60 S Kyrene Rd, #1, Chandler, AZ 85226-4685 | |
(480) 785-8700 | |
(480) 785-8787 |
Full Name | Dr Susan Chung |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 60 S Kyrene Rd, Chandler, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841399615 | NPI | - | NPPES |
00014245 | Other | BANNER HEALTH PLAN | |
1Z65553 | Other | HEALTHNET | |
713439 | Other | AZ | AHCCCS |
7134390 | Other | DES | |
713439001 | Other | APIPA | |
AZ0719840 | Other | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 30500 (Arizona) | Primary |
Entity Name | Phoenix Children's Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922112044 PECOS PAC ID: 0446278584 Enrollment ID: O20051107000704 |
News Archive
Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology.
CarePoint Health-Bayonne Medical Center has received the Mission: Lifeline Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.
University of Missouri Health Care has received the global HIMSS Enterprise Nicholas E. Davies Award of Excellence for health care technology innovations that are improving patient outcomes.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Susan Chung, MD 6301 S Mcclintock Dr, #101, Tempe, AZ 85283-3392 Ph: (480) 214-2300 | Dr Susan Chung, MD 60 S Kyrene Rd, #1, Chandler, AZ 85226-4685 Ph: (480) 785-8700 |
News Archive
Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology.
CarePoint Health-Bayonne Medical Center has received the Mission: Lifeline Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.
University of Missouri Health Care has received the global HIMSS Enterprise Nicholas E. Davies Award of Excellence for health care technology innovations that are improving patient outcomes.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.
› Verified 7 days ago
Dr. Shawn Kristian Centers, MD(H) Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2442 E Aloe Pl, Chandler, AZ 85286 Phone: 877-614-4673 | |
Dr. Ayesha Younas, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Road, Ste C104, Chandler, AZ 85224 Phone: 480-222-6770 Fax: 480-222-6771 | |
Dr. Sudha Chandrasekhar, M.D., M.P.H., IBCLC Pediatrics Medicare: Medicare Enrolled Practice Location: 205 S Dobson Rd, Suite 1, Chandler, AZ 85224 Phone: 480-963-6668 Fax: 480-963-6669 | |
Shabib A Alhadheri, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 936 W. Chandler Blvd., Suite #2, Chandler, AZ 85225 Phone: 480-855-1339 Fax: 480-857-0313 | |
Dr. Natalie A Teng, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 965 W Chandler Heights Rd, Chandler, AZ 85248 Phone: 480-460-4949 Fax: 480-460-5858 | |
Julia Tuleneva, FNP Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2905 W Warner Rd Ste 12, Chandler, AZ 85224 Phone: 480-831-8457 | |
Dr. David Michael Ciminello, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 965 W Chandler Heights Rd, Chandler, AZ 85248 Phone: 480-460-4949 Fax: 480-460-5858 |